LEADER 01578nam  2200457Ia 450 
001 9910698463703321
005 20230902161642.0
035   $a(CKB)4950000000094128
035   $a(OCoLC)527796511
035   $a(EXLCZ)994950000000094128
100   $a20100224d2009      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPharmaceutical R&D and the evolving market for prescription drugs$b[electronic resource]
210  1$a[Washington, D.C.] :$cCongressional Budget Office,$d[2009]
215   $a1 online resource (8 pages) $cillustrations
225 1 $aEconomic and budget issue brief
300   $aTitle from title screen (viewed on Feb. 24, 2010)
300   $a"October 26, 2009."
320   $aIncludes bibliographical references.
410  0$aEconomic and budget issue brief.
606   $aDrugs$xResearch$zUnited States
606   $aPharmacy$xResearch$zUnited States
606   $aPharmaceutical industry$zUnited States
606   $aPharmaceutical policy$zUnited States
615  0$aDrugs$xResearch
615  0$aPharmacy$xResearch
615  0$aPharmaceutical industry
615  0$aPharmaceutical policy
700   $aAustin$b David$01025688
701   $aBaker$b Colin$0176100
712 02$aUnited States.$bCongressional Budget Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698463703321
996   $aPharmaceutical R&D and the evolving market for prescription drugs$93492119
997   $aUNINA